Influence of Genotype of Drug Metabolizing Enzyme or Transporter on the Pharmacokinetics/Pharmacodynamics of Clopidogrel Completed Phase 4 Trials for Acetylsalicylic acid (DB00945)

IndicationStatusPhase
DBCOND0055242 (Influence of Genotype of Drug Metabolizing Enzyme or Transporter on the Pharmacokinetics/Pharmacodynamics of Clopidogrel)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01503658Clinical Trial to Evaluate the Influence of Genotype on the Pharmacokinetics/Pharmacodynamics of ClopidogrelTreatment